BIOMIRNA HOLDINGS LTD has a total of 26 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are BARRY THOMAS GERARD, PRIMAGEN HOLDING BV and INGENEUS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | Israel | 2 | |
#8 | China | 1 | |
#9 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Computer technology |
# | Name | Total Patents |
---|---|---|
#1 | Boeri Mattia | 21 |
#2 | Sozzi Gabriella | 21 |
#3 | Pastorino Ugo | 19 |
#4 | Gabriella Sozzi | 3 |
#5 | Mattia Boeri | 3 |
#6 | Ugo Pastorino | 3 |
Publication | Filing date | Title |
---|---|---|
US2017159125A1 | Micro-rna biomarkers for haemolysis and methods of using same | |
WO2016059241A2 | Lung cancer diagnostics and therapeutics with mir-660 | |
AU2014375224A1 | Lung cancer determinations using miRNA ratios | |
WO2016071729A1 | Methods of using micro-rna biomarkers for haemolysis detection | |
AU2012215105A1 | Micro -RNA biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof |